ArticleEuropean heart journal2026

Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.

Florian A Wenzl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.